Magazines - PharmaTimes
PharmaTimes Magazine. PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis. PharmaTimes print and digital ...
News - PharmaTimes
6 天之前 · NICE recommends remote monitoring technology for heart failure patients. 31st Oct 2024. Heart failure accounted for approximately 90,000 hospital admissions in England in 2019 to 2020.
PharmaTimes - June 2024
This issue is about the shaping, delivery and future of clinical trials – the exciting dawn of a new era for how therapies reach the marketplace. We cover the influence of digital, the radical shift in trial design and, above all, the need to incorporate patients at every stage. We’ve also got a review of our International Clinical Researcher of the Year bash – an unforgettable 25th ...
The ecosystem overtakes the producers in pharma and life sciences
2021年12月7日 · In June, Danaher joined other service companies in the top ten by announcing its $9.6bn acquisition of Aldevron, buying out PE houses EQT and TA Associates. Aldevron produces plasmid DNA, mRNA and proteins, supporting pharma and biotech clients in research, clinical and commercial stage work. The acquisition will expand Danaher’s capabilities ...
October 2021 - PharmaTimes
PharmaTimes - October 2021. As the world gears up for COP26, climate change and sustainability have been brought into sharp focus once again, with world leaders primed for talks on how to slow global warming. In this month’s issue, John Pinching examines how climate change has prompted an industry-wide shift for pharma (p16), one which has ...
Is pharma passing the test on access to medicine?
2021年1月27日 · The current COVID-19 pandemic is a litmus test of the resilience of health systems and of the pharmaceutical industry’s ability to address issues of access, affordability and sustained supply of medicines, diagnostics and vaccines.
Cold chain in 2021 - PharmaTimes
Dave Williams' predictions for COVID-19's continued influence on the industry. As we enter 2021 and reflect on 2020, the pandemic pushed pharmaceutical and cold chain industries to work in unprecedented ways to innovate through vaccine development, temperature-controlled packages that met the needs of new deep-frozen vaccine storage and ...
PharmaTimes - September 2021
PharmaTimes - September 2021. With social distancing restrictions easing in the UK, it has never been more important to evaluate the ongoing and expected changes arising from the global pandemic. Bearing that in mind, the effects of COVID-19 will continue to impact the pharmaceutical and healthcare sectors in various ways as we move into autumn ...
Powerful progress - PharmaTimes
2021年3月1日 · While COVID-19 undoubtedly brought great chaos and crises last year, it also fuelled incredible innovation and collaboration across the life sciences industry.
May 2022 - PharmaTimes
PharmaTimes - May 2022. It’s fair to say that certain aspects of our industry have taken a while to change – in some cases several centuries! Notably among these are public image, internal demographics, understanding the totality of ‘end users’ and, more recently, cyber adaptation. Perhaps all these roads lead to the all-encompassing ...